Results 11 to 20 of about 404,128 (166)

Hypertension and left ventricular hypertrophy. [PDF]

open access: yesAnnals of Translational Medicine, 2017
Left ventricular hypertrophy (LVH) is an abnormal increase in left ventricular mass. which is a marker for and contributes to coronary events, stroke, heart failure, peripheral arterial disease, and cardiovascular mortality in patients with hypertension (
W. Aronow
semanticscholar   +4 more sources

Moexipril and left ventricular hypertrophy

open access: yesVascular Health and Risk Management, 2007
George S Chrysant1, PK NguyenUniversity of Oklahoma, 1Director, Advanced Cardiac Imaging, INTEGRIS Heart Hospital, Oklahoma City, OK, USAAbstract: Angiotensin-converting enzyme (ACE) inhibitors today are the standard therapy of patients with myocardial ...
George S Chrysant, PK Nguyen
doaj   +2 more sources

Left ventricular hypertrophy: is it really? [PDF]

open access: yesJournal of Cardiovascular Magnetic Resonance, 2013
Background Patients with left ventricular hypertrophy (LVH), typically assessed by 2D echocardiography, are at a greater risk for heart failure and sudden cardiac death. An accurate diagnosis of LVH is essential to clinical evaluation and treatment. However, 2D echo has inferior spatial resolution and less than optimal measurement positioning, relative
Nicholas C Boniface   +6 more
openaire   +3 more sources

Left ventricular hypertrophy in athletes [PDF]

open access: yesEuropean Journal of Echocardiography, 2009
Participation in regular intensive exercise is associated with a modest increase in left ventricular wall thickness (LVWT) and cavity size. The magnitude of these physiological changes is predominantly determined by a variety of demographic factors which include age, gender, size, ethnicity, and sporting discipline.
Amit Bhan, John Rawlins, Sanjay Sharma
openaire   +3 more sources

Left ventricular hypertrophy [PDF]

open access: yesBMJ, 1995
Left ventricular hypertrophy is often assumed to be little more than a marker for hypertension. In fact, the relation between diastolic or systolic blood pressure and left ventricular mass is not always close.1 2 Left ventricular hypertrophy is an independent risk factor for myocardial infarction and death in men and women with hypertension3 4 and in ...
openaire   +3 more sources

Left Ventricular Hypertrophy and Hypertension

open access: yesClinical and Experimental Hypertension, 1993
The level of left ventricular (LV) mass as measured by echocardiography or other techniques in hypertensive patients reflects the integrated effects of the level of arterial pressure, the concomitant volume load imposed on the heart, and of alterations in arterial waveform morphology as well as of body size and non-hemodynamic variables.
Devereux RB   +5 more
openaire   +4 more sources

FGF23 and Left Ventricular Hypertrophy in Children with CKD.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2018
BACKGROUND AND OBJECTIVES High plasma concentration of fibroblast growth factor 23 (FGF23) is a risk factor for left ventricular hypertrophy (LVH) in adults with CKD, and induces myocardial hypertrophy in experimental CKD. We hypothesized that high FGF23
M. Mitsnefes   +8 more
semanticscholar   +1 more source

Skin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD.

open access: yesJournal of the American Society of Nephrology, 2017
The pathogenesis of left ventricular hypertrophy in patients with CKD is incompletely understood. Sodium intake, which is usually assessed by measuring urinary sodium excretion, has been inconsistently linked with left ventricular hypertrophy.
Markus P. Schneider   +17 more
semanticscholar   +1 more source

Left ventricular hypertrophy and insulin resistance in adults from an urban community in The Gambia: cross-sectional study.

open access: yesPLoS ONE, 2014
ObjectiveTo determine the association between left ventricular hypertrophy and insulin resistance in Gambians.DesignCross-sectional study.SettingOutpatient clinics of Royal Victoria Teaching Hospital and Medical Research Council Laboratories in Banjul ...
Bernard Cudjoe Nkum   +3 more
doaj   +1 more source

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible

open access: yesScientific Reports, 2017
Fibroblast growth factor (FGF) 23 is a phosphaturic hormone that directly targets cardiac myocytes via FGF receptor (FGFR) 4 thereby inducing hypertrophic myocyte growth and the development of left ventricular hypertrophy (LVH) in rodents.
A. Grabner   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy